Director Trevor Bezdek of GoodRx Holdings, Inc. filed a Form 4 on November 3, 2026, reporting the vesting and acquisition of 34,975 restricted stock units converted to Class A Common Stock on November 2, 2026, listed on NASDAQ:GDRX.

Key Highlights

  • Transaction: 34,975 restricted stock units (RSUs) were acquired (transaction code M) on November 2, 2026, with a price of $0 for the derivative security.
  • Direct ownership after transaction: Bezdek directly holds 378,785 shares of Class A Common Stock following the reported transaction.
  • Remaining RSUs: Bezdek holds 69,950 RSUs directly after the transaction.
  • Vesting schedule: The RSU award vests as to one-third of the shares on each of the first three anniversaries of the grant date, beginning November 2, 2026, subject to continued service.
  • Indirect holdings: Bezdek also holds shares indirectly through two grantor retained annuity trusts (TB 2024-2 GRAT: 543,377 shares; TB 2025 GRAT: 2,089,343 shares), one share via spouse, and disclaims beneficial ownership of two additional GRATs (JB 2024-2 GRAT: 543,377 shares; JB 2025 GRAT: 2,089,343 shares).
  • Disclaimer: According to the filing, Bezdek "has no pecuniary interest in or voting or investment control over" the shares held by the JB 2024-2 GRAT and JB 2025 GRAT and disclaims beneficial ownership of those shares.

Bezdek RSU Vesting and Beneficial Ownership at GoodRx Holdings

According to the Form 4 filed on November 3, 2026, Trevor Bezdek, a director of GoodRx Holdings, Inc. (NASDAQ:GDRX), reported the acquisition of 34,975 shares of Class A Common Stock on November 2, 2026, resulting from the vesting of an equal number of restricted stock units. The filing states that each restricted stock unit represents a contingent right to receive one share of Class A Common Stock. The price of the derivative security is listed as $0.

Following the transaction, Bezdek directly beneficially owns 378,785 shares of Class A Common Stock and retains 69,950 RSUs directly. The filing also discloses indirect ownership through two grantor retained annuity trusts for which Bezdek serves as sole trustee and sole annuitant: the TB 2024-2 GRAT (543,377 shares) and the TB 2025 GRAT (2,089,343 shares). Additionally, one share is held indirectly by Bezdek's spouse.

The filing notes two further GRATs, the JB 2024-2 GRAT and JB 2025 GRAT, each holding 543,377 and 2,089,343 shares respectively, controlled by Jana Bezdek as sole trustee and sole annuitant. For both trusts, the filing states that Bezdek "has no pecuniary interest in or voting or investment control over the shares" and that "this filing is not an admission or acknowledgment that the Reporting Person is the beneficial owner of such shares." The form was signed by Gracye Cheng as attorney-in-fact for Trevor Bezdek on November 3, 2026.

What Was Disclosed

The filing reports Trevor Bezdek's acquisition of 34,975 Class A Common Stock shares via RSU vesting on November 2, 2026, his resulting direct and indirect ownership positions, and a disclaimer of beneficial ownership over shares held in two trusts controlled by his spouse.